Head Of Mission - Luis Neira(@MSF_EswatiniHoM) 's Twitter Profile Photo

Celebrate victories and confront obstacles in our fight against tuberculosis. Chaired by Dr. Debrah Vambe, learn from the PRACTECAL TB Trial team and other expert speakers as they celebrate successes and share innovative ways of addressing challenges in the TB arena.

Celebrate victories and confront obstacles in our fight against tuberculosis. Chaired by Dr. Debrah Vambe, learn from the PRACTECAL TB Trial team and other expert speakers as they celebrate successes and share innovative ways of addressing challenges in the TB arena.

#MSFSciDay
account_circle
Head Of Mission - Luis Neira(@MSF_EswatiniHoM) 's Twitter Profile Photo

in has started. Keep following our pages through the day as each session promises insights, discussions, and solutions to pressing healthcare challenges. Don't miss out - join us at
msf.org.uk/msf-scientific…

sSA2024!

#MSFSciDay in #Eswatini has started. Keep following our pages through the day as each session promises insights, discussions, and solutions to pressing healthcare challenges. Don't miss out - join us at 
msf.org.uk/msf-scientific…

#MSFSciDaysSA2024!
account_circle
MSF Science(@MSFsci) 's Twitter Profile Photo

Dr Animesh Sinha starts off the 2nd session on at talking about the success & challenges on the 6 month multidrug-resistant tuberculosis regimens: from trials to practice.

Don't miss out - join to learn the exciting development ➡️msf.org.uk/msf-scientific…

Dr Animesh Sinha starts off the 2nd session on #TB at #MSFSciDay talking about the success & challenges on the 6 month multidrug-resistant tuberculosis regimens: from trials to practice. 

Don't miss out - join to learn the exciting development ➡️msf.org.uk/msf-scientific…
account_circle
Temmy Sunyoto(@SunyotoTemmy) 's Twitter Profile Photo

Exciting day for exchanges and strengthening in ! Ranging from , , and wait for our MSF LuxOR study in in camps later on. Stay tuned @MSFSouthAsia sciday

Exciting day for exchanges and strengthening #research in #MSF! Ranging from #TB, #NCD, #NTDs and wait for our @MSFLuxOR study in #scabies in #Rohingya camps later on. Stay tuned @MSFSouthAsia #MSFsciday
account_circle
Doctors Without Borders (MSF) Southern Africa(@MSF_southafrica) 's Twitter Profile Photo

in has started. Follow MSF Science throughout the day to stay updated. Each session promises insights, discussions, and solutions to pressing healthcare challenges. Take advantage of this—join us👉 msfsa.me/3vZYMh9

#MSFSciDay in #Eswatini has started. Follow @MSFsci throughout the day to stay updated. Each session promises insights, discussions, and solutions to pressing healthcare challenges. Take advantage of this—join us👉 msfsa.me/3vZYMh9
account_circle
MSF Science(@MSFsci) 's Twitter Profile Photo

Check out this interesting session on 'Improving treatment of multidrug-resistant ' by Dr Kunda K. Mikanda at .

He talks about the results from the endTB clinical trial
Exciting opportunity to listen👉 bit.ly/3U07J1Z

Check out this interesting session on 'Improving treatment of multidrug-resistant #TB' by Dr Kunda K. Mikanda at #MSFSciDay. 

He talks about the results from the endTB clinical trial 
Exciting opportunity to listen👉 bit.ly/3U07J1Z
account_circle
MSF South Asia(@MSF_SouthAsia) 's Twitter Profile Photo

'MDRTB is a rising global concern. We strongly recommend taking proactive steps to improve treatment compliance & emphasizing adherence as an important step. A patient-centric approach is the need of the hour,' -- Sonali Bhattacharjee

'MDRTB is a rising global concern. We strongly recommend taking proactive steps to improve treatment compliance & emphasizing adherence as an important step. A patient-centric approach is the need of the hour,' -- Sonali Bhattacharjee
#MSFsciDay
account_circle
K(@meanbones) 's Twitter Profile Photo

Moving keynote speech by Nandita V on surviving TB at MSFsciday, but the journey still continues. Thank you for sharing your story is all I can say.

account_circle
MSF HIV(@MSF_HIV) 's Twitter Profile Photo

Despite high mobility, stigma, majority agreed to tests in 's Moz/Malawi proj, but retesting major challenge SciDay

account_circle